Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant (Q44788259)

6 December 2017

title

Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant (English)

1 reference

6 December 2017

Niclas Rydell

1 reference

6 December 2017

Ingvar Sjöholm

series ordinal

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

6 December 2017

1 reference

6 December 2017

1 reference

6 December 2017

issue

9-10

1 reference

6 December 2017

page(s)

1265-1274

1 reference

Antibody persistence four years after primary immunization of infants and toddlers with Haemophilus influenzae type b CRM197 conjugate vaccine

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Mucosal immunity and tolerance: relevance to vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Biodegradable microspheres. IV: Factors affecting the distribution and degradation of polyacryl starch microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Polyacryl starch microparticles as adjuvant in oral immunisation, inducing mucosal and systemic immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Biodegradable microspheres. XVIII: The adjuvant effect of polyacryl starch microparticles with conjugated human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Characterization of polyacryl starch microparticles as carriers for proteins and drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Immunity to diphtheria in a sample of adult population fron central Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Immunity to diphtheria in young British adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Immunization against diphtheria with special emphasis on immunization of adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Diphtheria: Incidence Trends and Age-wise Changes of Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Molecular epidemiology of the 1984-1986 outbreak of diphtheria in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

An immunological study of the diphtheria toxin molecule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Immunogenic correlation between cross-reacting material (CRM197) produced by a mutant of Corynebacterium diphtheriae and diphtheria toxoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

Differences in the immunogenicity of native and formalinized cross reacting material (CRM197) of diphtheria toxin in mice and guinea pigs and their implications on the development and control of diphtheria vaccine based on CRMs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

A possible explanation for the discrepancy between ELISA and neutralising antibodies to tetanus toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.034

10.1016/J.VACCINE.2003.09.034

7 January 2021

Identifiers

DOI

1 reference

6 December 2017

1 reference